Learn more

TROPHOS

Overview
  • Total Patents
    128
  • GoodIP Patent Rank
    206,085
  • Filing trend
    ⇩ 100.0%
About

TROPHOS has a total of 128 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are CORTRIA CORP, ARACHNOVA THERAPEUTICS LTD and SHANGHAI INST OF CYTOBIOLOGY C.

Patent filings per year

Chart showing TROPHOSs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Drouot Cyrille 65
#2 Pruss Rebecca 51
#3 Bordet Thierry 39
#4 Chaimbault Corinne 26
#5 Buisson Bruno 24
#6 Berna Patrick 17
#7 Delaage Michel 17
#8 Nazih Abdesslame 11
#9 Bassissi Firas 9
#10 Schaller Sophie 9

Latest patents

Publication Filing date Title
AU2013203682A1 Liposome comprising at least one cholesterol derivative
FR2979239A1 Liposome comprising at least one cholesterol derivative
FR2940650A1 Novel oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions comprising the same, and process for preparing the same
US2010310674A1 Novel composition for treating the side effects of anticancer treatments
FR2934596A1 Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions comprising them, and process for preparing the same
FR2919182A1 Use of at least one oxime derivative of 3,5-seco-4-nor-cholestane as antioxidants
FR2919180A1 Use of at least one oxime cholest-4-en-3-one derivative as antioxidants
FR2914188A1 New cholest-4-en-3-one oxime composition
FR2899108A1 Use of cholest-4-en-3-one derivatives for the production of a cytoprotective medicine
AU2004222540A1 Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof
FR2860159A1 Use of cholest-4-en-3-one oxime as a neuroprotective medicament
FR2852246A1 Medicaments containing new or known cholestenone derivatives, useful for treating neurodegenerative or GABA(A)-receptor mediated diseases, e.g. amyotrophic lateral sclerosis, neuropathic pain or depression
FR2845488A1 Optical device for observing samples on a support, in particular for a cytometer
FR2834566A1 Device for positioning a sample analysis plate on an observation device
FR2817867A1 Isocoumarins inhibitors of amyloid peptide production, preparation, compositions containing same and uses thereof
FR2808888A1 Sequential sample observation device and methods using the same
EP1107003A1 Methods for screening compounds active on neurons